Duramune Puppy DP + C
Duramune Puppy DP + C
Not authorised
- Canine distemper virus, strain Onderstepoort, Live
- Canine parvovirus, strain SAH, Live
- Canine coronavirus, strain TN449, Inactivated
Product identification
Medicine name:
Duramune Puppy DP + C
DURAMUNE PUPPY DP+C-RINUNCIATO
Active substance:
- Canine distemper virus, strain Onderstepoort, Live
- Canine parvovirus, strain SAH, Live
- Canine coronavirus, strain TN449, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, strain Onderstepoort, Live4.80/50% tissue culture infectious dose1.00millilitre(s)
-
Canine parvovirus, strain SAH, Live6.50/50% tissue culture infectious dose1.00millilitre(s)
-
Canine coronavirus, strain TN449, Inactivated2.00/relative potency1.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AH04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Italy
Package description:
- Pack with 100 x 1 ml doses
- Pack with 50 x 1 ml doses
- Pack with 25 x 1 ml doses
- Pack with 10 x 1 ml doses
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Italia S.r.l
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Ministry Of Health
Authorisation number:
- 103754
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0289/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Italian (PDF)
Published on: 3/06/2022